Hyaluronan is the general term designating the linear repeating
disaccharide, (beta-D-glucuronyl-beta-D-N-acetyl-glucosamine)
of very high molecular mass (upwards of 10x106
Daltons).
The molecular weight of Hyaluronan varies between different
tissues and species. It may also vary depending on the condition
of the tissue. For example, the molecular weight of Hyaluronan
in synovial fluid (normally 4-5 million Daltons) is often
reduced in joint disorders.
There are on average around 2500 repeating disaccharide units in
endogenous Hyaluronan and the mean molecular weight is
approximately 400 Daltons. However, the number of repeating
disaccharides in a Hyaluronan molecule can reach 10,000 or more,
with a molecular weight of around 4 million Daltons.)
The term “hyaluronic acid” was adopted when the biopolymer
was first isolated from the vitreous of bovine eyes in 1934. However,
under physiological conditions, hyaluronan is not present in the
acid form, therefore this term is redundant. The term “sodium
hyaluronate” mostly designates the highly purified, narrow
molecular weight range hyaluronan used as a therapeutic agent.
These different terms specify only the natural, non-chemically
modified biopolymer which is present in most of the body tissues.
Hyaluronan is nearly ubiquitous in its distribution being present
in the interstitial spaces of most animal tissues.
Its principal role is as a structural element but functions may
differ depending on its location in the body.
Hyaluronan can also:
- Play a significant role in the body during repair process, mediating
cell adhesion, differentiation, motility and blood vessel growth;
- Retain large quantities of water and therefore control
tissue hydration;
- Protect tissue against overuse and shocks by its viscoelastic
properties.
Hyaluronan depletion in tissues is often associated
to pathological states such as
some cancers, skin diseases, osteoarthritis
and rheumatoid arthritis.
The human joint lined by the synovial membrane and is filled with
a viscous fluid called the synovial fluid (SF), which can be regarded
as a modified extra-cellular fluid. Like other extra-cellular fluids,
the SF acts as a transport medium supplying the articular cartilage
with nutrients and oxygen and carrying away the waste products
of metabolism. The main component of the SF is hyaluronan. The
SF contains a complex solution of proteins, electrolytes, uric
acid and glucose, in concentrations similar to blood plasma. Hyaluronan
is constantly produced by the synoviocytes present in the synovial
membrane and then extruded in the synovial space. There is a strict
balance between its production and degradation.
The SF has principally protective functions in the joint, acting
as a lubricant, shock absorber and ‘filter’, and plays
a key role in the maintenance of joint homeostasis. An important
point of hyaluronan is that the meshworks it forms are ordered.
The shapes of the hyaluronan secondary structures determine the
shapes of the aggregates, and each branch in the meshwork carries
with it two intrinsic directions, up or down, established by the
hyaluronan chains. This ordered meshwork is of importance depending
on the situation the hyaluronan solution is placed. (Balazs et
al. 1993)
Hyaluronan solutions, and as such the synovial fluid, are viscoelastic.
This means that the solution presents viscous and elastic characteristics
at the same time. The viscosity is important providing lubrication
when the solution is subjected to gradual shear stress. Hyaluronan
solutions present non-Newtonian behaviour. This means that the
viscosity decreases when the shear stress increases thus increasing
lubrication. Example: the synovial fluid lubricates the joint when
walking.
The elasticity is important when a sudden loading force is applied
to hyaluronan solutions. In that case, hyaluronan chains first
absorb the loading force and then release it in a proper manner
(shock absorbing properties). Example: absorption of shocks between
boneheads when running.
Due to its properties in solution hyaluronan forms meshworks that
restrict the free movement of cells and large molecules through
the joint, acting as a sort of filter. In fact the hyaluronan meshwork
forms ‘pores’ which allow the free passage of small
molecules, such as nutrients, but effectively block the passage
of larger molecules, such as inflammatory cells or proteins. The
hyaluronan chains are constantly moving in the solution, and the
effective “pores” in the network continuously change
in size. Statistically, all sizes of pores can exist, but with
different probabilities. This means that in principle, all molecules
can pass through a hyaluronan network, but with different degrees
of retardation depending on their hydrodynamic volumes. This is
very important as the hyaluronan in the synovial fluid can help
to modulate the inflammatory response.
The hyaluronan contained in the SF also helps to form a coating
layer over the entire inner surface of the joint. This layer is
formed mainly from hyaluronan, in association with proteins, and
is approximately 2um thick. It plays several important roles in
the protection of the articular cartilage including lubrication
and a ‘barrier function’. The hyaluronan layer is constantly
degraded and renewed.
The SF constantly supplies the hyaluronan layer with new molecules.
In the healthy joint, this constant process is very important in
the maintenance of joint homeostasis. Hyaluronan is present at
different levels in the joint (Abatangelo et al. 1995). At each
level, hyaluronan will play a different role: In the synovial tissues
thus forming a protective barrier: this barrier protects the synovium
against inflammatory mediators and shields pain receptors from
pain mediators thus modulating pain perception; ß (fibroblast-like)
cells of the synovium and is secreted into the synovial fluid.